Cerebral phosphorus metabolite abnormalities in opiate-dependent polydrug abusers in methadone maintenance

Psychiatry Research - Neuroimaging

Volumn 90, Issue 3, 1999, Pages 143-152

  Kaufman, Marc J ^a   Pollack, Mark H ^b   Villafuerte, Rosemond A ^a   Kukes, Thellea J ^a   Rose, Stephanie L ^a   Mendelson, Jack H ^a   Cohen, Bruce M ^a   Renshaw, Perry F ^a  

^a MCLEAN HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Brain; Cerebral blood flow; Cerebral metabolism; Heroin; Magnetic resonance spectroscopy; Substance dependence

Indexed keywords

METHADONE; OPIATE; PHOSPHORUS; PHOSPHORUS 31;

ADULT; ARTICLE; BRAIN BLOOD FLOW; BRAIN METABOLISM; BRAIN SCINTISCANNING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABUSE; FEMALE; HUMAN; MALE; METABOLITE; METHADONE TREATMENT; OCCIPITAL CORTEX; OPIATE ADDICTION; ORBITAL CORTEX; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

ADULT; BRAIN; CASE-CONTROL STUDIES; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METHADONE; MIDDLE AGED; NARCOTICS; OPIOID-RELATED DISORDERS; PHOSPHORUS;

EID: 0032769719     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(99)00017-7     Document Type: Article

References (48)

1. Ball J.C., Ross A. The Effectiveness of Methadone Maintenance Treatment: Patients, Programs, Services, and Outcome. 1991;Springer-Verlag, New York.
2. 31P MR spectroscopy study. Magnetic Resonance in Medicine. 35:1996;658-663.
3. Cooper, J.R., Altman, F., Brown, B.S., Czechowicz, D., 1983. Research on the Treatment of Narcotic Addiction. State of the Art., NIDA Treatment Research Monograph Series, DHHS Pub. No. (ADM)83-1281. US Dept. of Health and Human Services, Rockville, MD.
4. Danos P., Kasper S., Grunwald F., Klemm E., Krappel C., Broich K., Hoflich G., Overbeck B., Biersack H.J., Moller H.J. Pathological regional cerebral blood flow in opiate-dependent patients during withdrawal: an HMPAO-SPECT study. Neuropsychobiology. 37:1998;194-199.
5. Danos P., Van Roos D., Kasper S., Bromel T., Broich K., Krappel C., Solymosi L., Moller H. Enlarged cerebrospinal fluid spaces in opiate-dependent male patients: a stereological CT study. Neuropsychobiology. 38:1998;80-83.
6. de la Torre J.C., Fortin T., Park G.A., Butler K.S., Kozlowski P., Pappas B.A., de Socarraz H., Saunders J.K., Richard M.T. Chronic cerebrovascular insufficiency induces dementia-like deficits in aged rats. Brain Research. 582:1992;186-195.
7. Flogel U., Niendorf T., Serkowa N., Brand A., Henke J., Leibfritz D. Changes in organic solutes, volume, energy state, and metabolism associated with osmotic stress in a glial cell line: a multinuclear NMR study. Neurochemical Research. 20:1995;793-802.
8. Gerra G., Calbiani B., Zaimovic A., Sartori R., Ugolotti G., Ippolito L., Delsignore R., Rustichelli P., Fontanesi B. Regional cerebral blood flow and comorbid diagnosis in abstinent opioid addicts. Psychiatry Research. 83:1998;117-126.
9. Glanz M., Klawansky S., McAullife W., Chalmers T. Methadone vs. L-alpha-acetylmethadol (LAAM) in the treatment of opiate addiction. A meta-analysis of the randomized, controlled trials. American Journal of Addiction. 6:1997;339-349.
10. 31P-NMR on developing dog brain. FEBS Letters. 178:1984;137-142.
11. Holman B.L., Carvalho P.A., Mendelson J., Teoh S.K., Nardin R., Hallgring E., Hebben N., Johnson K.A. Brain perfusion is abnormal in cocaine-dependent polydrug users: a study using technetium-99m-HMPAO and ASPECT. Journal of Nuclear Medicine. 32:1991;1206-1210.
12. 31P magnetic resonance spectroscopy of chronic cerebral infarction in rats. NMR in Biomedicine. 2:1989;83-86.
13. Iguchi M.Y., Stitzer M.L., Bigelow G.E., Liebson I.A. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug and Alcohol Dependence. 22:1988;1-7.
14. 31P-NMR study of brain phospholipid structures in vivo. Biochimica et Biophysica Acta. 1085:1991;257-264.
15. Klunk W., Xu C.-J., Panchalingam K., McClure R., Pettegrew J. Analysis of magnetic resonance spectra by mole percent: comparison to absolute units. Neurobiology of Aging. 15:1994;133-140.
16. Kosten T.R., Schottenfeld R., Ziedonis D., Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease. 181:1993;358-364.
17. Kosten T.R., Cheeves C., Palumbo J., Seibyl J.P., Price L.H., Woods S.W. Regional cerebral blood flow during acute and chronic abstinence from combined cocaine-alcohol abuse. Drug and Alcohol Dependence. 50:1998;187-195.
18. Krystal J.H., Woods S.W., Kosten T.R., Rosen M.I., Seibyl J.P., van Dyck C.C., Price L.H., Zubal I.G., Hoffer P.B., Charney D.S. Opiate dependence and withdrawal: preliminary assessment using single photon emission computerized tomography (SPECT). American Journal of Drug and Alcohol Abuse. 21:1995;47-63.
19. Laptook A.R., Hassan A., Peterson J., Corbett R.J., Nunnally R.L. Effects of repeated ischemia on cerebral blood flow and brain energy metabolism. NMR in Biomedicine. 1:1988;74-79.
20. Levin J.M., Holman B.L., Mendelson J.H., Teoh S.K., Garada B., Johnson K.A., Springer S. Gender differences in cerebral perfusion in cocaine abuse: 99mTc-HMPAO SPECT study of drug abusing women. Journal of Nuclear Medicine. 35:1994;1902-1909.
21. Levin J.M., Mendelson J.H., Holman B.L., Teoh S.K., Garada B., Schwartz R.B., Mello N.K. Improved regional cerebral blood flow in chronic cocaine polydrug users treated with buprenorphine. Journal of Nuclear Medicine. 36:1995;1211-1215.
22. London E.D., Margolin R.A., Wong D.F., Links J., La France N.D., Cascella N.G., Broussolle E.P.M., Wagner H.N. Jr., Snyder F.R., Jasinski D.R. Cerebral glucose utilization in human heroin addicts: case reports from a positron emission tomographic study. Research Communications in Substances of Abuse. 10:1989;141-144.
23. MacKay S., Meyerhoff D., Dillon W., Weiner M., Fein G. Alteration of brain phospholipid metabolites in cocaine-dependent polysubstance abusers. Biological Psychiatry. 34:1993;261-264.
24. McLellan A.T., Luborsky L., O'Brien C.P. Is treatment for substance abuse effective? Journal of the American Medical Association. 247:1982;1423-1428.
25. McLellan A.T., Childress A.R., Ehrman R., O'Brien C.P., Pashko S. Extinguished conditioned responses during opiate dependence treatment: turning laboratory findings into clinical procedures. Journal of Substance Abuse Treatment. 3:1986;33-40.
26. Meyerhoff D.J., MacKay S., Sappey-Marinier D., Deicken R., Calabrese G., Dillon W.P., Weiner M.W., Fein G. Effects of chronic alcohol abuse and HIV infection on brain phosphorus metabolites. Alcoholism: Clinical and Experimental Research. 19:1995;685-692.
27. 31P NMR spectra in vivo. Magnetic Resonance in Medicine. 12:1989;282-289.
28. National Institute on Drug Abuse, 1997. NIDA Research Report: Heroin Abuse and Addiction. NIH Pub. No. 97-4165. http://www.nida.nih.gov/ResearchReports/Heroin/Heroin.html.
29. National Institutes of Health, 1997. Effective Medical Treatment of Opiate Addiction. NIH Consensus Statement, 15, pp. 1-38.
30. Nurco D.N., Shaffer J.W., Hanlon T.E., Kinlock T.W., Duszynski K.R., Stephenson P. Relationships between client/counselor congruence and treatment outcome among narcotic addicts. Comprehensive Psychiatry. 29:1988;48-54.
31. O'Connor P.G., Oliveto A.H., Shi J.M., Triffleman E.G., Carroll K.M., Kosten T.R., Rounsaville B.J., Pakes J.A., Schottenfeld R. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic. American Journal of Medicine. 105:1998;100-105.
32. Ordidge R.J., Connelly A., Lohman J. A general approach to selection of multiple cubic volume elements using the ISIS technique. Journal of Magnetic Resonance. 66:1986;283-294.
33. 31P nuclear magnetic resonance spectroscopy. Neurology. 35:1985;781-788.
34. 31P Nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations. Journal of Neuropathology and Experimental Neurology. 46:1987;419-430.
35. Pettegrew J.W., Panchalingam K., Klunk W.E., McClure R.J., Muenz L.R. Alterations of cerebral metabolism in probable Alzheimer's disease: a preliminary study. Neurobiology of Aging. 15:1994;117-132.
36. Pezawas L.M., Fischer G., Diamant K., Schneider C., Schindler S.D., Thurnher M., Ploechl W., Eder H., Kasper S. Cerebral CT findings in male opioid-dependent patients: stereological, planimetric and linear measurements. Psychiatry Research. 83:1998;139-147.
37. Raichle M.E., Grubb R.L.J., Gado M.H., Eichling J.O., Ter-Pogossian M.M. Correlation between regional cerebral blood flow and oxidative metabolism. In vivo studies in man. Archives of Neurology. 33:1976;523-526.
38. Rose J.S., Branchey M., Buydens-Branchey L., Stapleton J.M., Chasten K., Werrell A., Maayan M.L. Cerebral perfusion in early and late opiate withdrawal: a technetium-99m-HMPAO SPECT study. Psychiatry Research: Neuroimaging. 67:1996;39-47.
39. Serkova N., Brand A., Christians U., Leibfritz D. Evaluation of the effects of immunosuppressants on neuronal and glial cells in vitro by multinuclear magnetic resonance spectroscopy. Biochimica et Biophysica Acta. 1314:1996;93-104.
40. Sokoloff L. Relationships among local functional activity, energy metabolism, and blood flow in the central nervous system. Federation Proceedings. 40:1981;2311-2316.
41. Stitzer M.L., Iguchi M.Y., Felch L.J. Contingent take-home incentive: effects on drug use of methadone maintenance patients. Journal of Consulting and Clinical Psychology. 60:1992;927-934.
42. Strain E.C., Stitzer M.L., Liebson I.A., Bigelow G.E. Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. Journal of Clinical Psychopharmacology. 16:1996;58-67.
43. Strang J., Gurling H. Computerized tomography and neuropsychological assessment in long-term high-dose heroin addicts. British Journal of Addiction. 84:1989;1011-1019.
44. Strickland T.L., Mena I., Villanueva M.J., Miller B.L., Cummings J., Mehringer C.M., Satz P., Myers H. Cerebral perfusion and neuropsychological consequences of chronic cocaine use. Journal of Neuropsychiatry and Clinical Neuroscience. 5:1993;419-427.
45. Tims F.M., Ludford J.P. Drug Abuse Treatment Evaluation: Strategies, Progress, and Prospects, NIDA Research Monograph, Vol 51. 1984;DHHS Pub. No. (ADM)84-1329. US Dept. of Health and Human Services, Rockville, MD.
46. Torrens M., San L., Martinez A., Castillo C., Domingo-Salvany A., Alonso J. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction. 92:1997;707-716.
47. 31P MRS: absolute concentrations, signal-to-noise and prior knowledge. NMR in Biomedicine. 8:1995;87-93.
48. Volkow N.D., Mullani N., Gould K.L., Adler S., Krajewski K. Cerebral blood flow in chronic cocaine users: a study with positron emission tomography. British Journal of Psychiatry. 152:1988;641-648.